Lupus nephritis is associated with thickening of the glomerular basement membrane. Here we measured expression of proteins involved in extracellular matrix turnover in kidneys of lupus-prone mice of the NZBxNZW F1 (B/W) strain before the onset of the disease until the development of proteinuria. Expression of the major isoforms of glomerular basement collagen IV (a3/a4/a5) was unchanged throughout disease progression. Collagen IV a1 and a2, however, were highly upregulated at the proteinuric stage while collagen IV a6 was increased at all time points compared to normal mice. There was increased expression of matrix metalloproteinase-2 and -9, their protein inhibitors TIMP-1 and -2 and the metalloproteinase-9 stabilizing protein lipocalin-2 in kidneys of nephritic lupus-prone mice. When proteinuria appeared we found an increased net glomerular gelatinolytic activity. These studies suggest that matrix metalloproteinases contribute to extracellular matrix expansion and proteinuria by altering matrix composition.
Systemic lupus erythematosus is a systemic autoimmune disease characterized by chronic inflammatory processes associated with deposition of immune complexes in different organs. The glomerulus is one of the sites most seriously affected, with tissue damage progressing to end-stage renal disease in as much as 30% of patients. Although various functional disturbances within tissues have been implicated in the pathogenesis of systemic lupus erythematosus, details of the initiating events and accompanying detrimental processes on both systemic and end-organ levels remain largely unknown.
The histological presentation and patterns of glomerular injury in lupus nephritis are heterogeneous, with varying involvement of mesangial and vascular elements. An invariant finding, however, is the accumulation of immune complexes within glomerular membranes, which is often accompanied by an apparent expansion of vascular and/or mesangial extracellular matrices as the disease progresses. The causes underlying the observed glomerular basement membrane (GBM) thickening are unknown, but it has been speculated that increased synthesis or decreased turnover of extracellular matrix constituents such as collagen IV might be contributing factors. [1] [2] [3] On the basis of gene expression and immunohistochemical data, previous studies have reported increases in collagen IV in mice with chronic graft-versus-host disease-another model of lupus nephritis. 4, 5 Autoantibodies against dsDNA are considered to be an important factor in the evolution of lupus nephritis. Several nephritogenic anti-dsDNA antibodies appear to bind DNA in the form of nucleosomes, and extracellular chromatin has been found to colocalize with such antibodies in situ. 6, 7 Recent data from our group demonstrated considerable affinity of nucleosomes for collagen IV. 8 Within this context, increased production or reduced degradation of collagen IV might theoretically contribute to accumulation of extracellular chromatin, thus maintaining or aggravating autoantibody deposition. We therefore aimed to look at the changes occurring in extracellular matrix composition and turnover around the time of appearance of glomerular immune complexes and the onset of nephritis.
Matrix metalloproteinases (MMPs) represent a family of endopeptidases that play a key role in the turnover of extracellular matrix proteins, and altered expression of MMPs is believed to be involved in the development of several glomerulopathies.
9,10 MMP-2 and MMP-9, referred to as the gelatinases, have collagen IV among their main substrates, and increased gene expression of these particular MMPs has been especially implicated in glomerulonephritis, including both human 10 and murine 11 lupus nephritis. However, natural inhibitors of MMP activity, the tissue inhibitors of metalloproteinases (TIMPs), are also differentially expressed in nephritis, [12] [13] [14] complicating the interpretation of net effects on in vivo proteolytic activity.
We have followed the time course of the development of nephritis in a mouse model of lupus nephritis, NZBxNZW F1 (B/W) mice, analyzing gene expression patterns for collagen IV, MMP-2, MMP-9, and TIMP 1-4 within the kidneys at prenephritic stages and at the onset of proteinuria. On the basis of findings of altered levels of expression of MMP-2, MMP-9, TIMP-1, and TIMP-2, we examined the net effect in vivo on renal gelatinolytic activity utilizing an in situ zymography assay.
RESULTS
The B/W mouse is an extensively studied model of systemic lupus erythematosus, 15 and mice of this breed develop antidsDNA antibodies from a relatively early age. 16 We detected no anti-dsDNA antibodies in serum from young B/W mice or BALB/c controls. Moderate increase in the titer was first observed in the 20-week-old (w.o.) B/W, with a further increase toward development of proteinuria ( Figure 1a) .
Transmission electron microscopy (TEM) analysis of B/W glomeruli revealed normal membranes in 4 and 8 w.o. mice (Figure 1b and c) . Whereas only focal membrane irregularities were found in the 20 w.o. B/W mice (Figure 1d ), dramatic changes involving thickening of capillary membranes and mesangial matrix along with the presence of electron-dense structures and fused podocyte processes were seen in the proteinuric animals ( Figure 1e ). These electrondense structures, typical of lupus nephritis, have been shown to colocalize with autoantibody deposits. 7, 17 Alterations in ECM composition during development of nephritis Kidney morphology was examined at the age of 4, 8, and 20 weeks as well as at the onset of proteinuria in both B/W and age-matched BALB/c controls. There was no significant matrix expansion in young, nonproteinuric mice as determined by hematoxylin and eosin or periodic acid schiff (PAS) staining (Figure 2a ), whereas mild expansion and increased cellularity was seen in the 20 w.o. B/W mice (Figure 2b ). At the onset of proteinuria, the animals showed significant expansion of the mesangial matrix and disruption of glomerular architecture (Figure 2c ). No such changes were found in the age-matched BALB/c controls (Figure 2d ).
Immunofluorescence staining against collagen IV reveals expansion of perivascular and mesangial collagen matrix at proteinuria compared with prenephritic mice (Figure 2e and f), consistent with histological and TEM findings of matrix expansion.
The main collagen IV isoform present in the GBM consists of trimers of chains a3-a5, organized into a3/a4/a5(IV) heteropolymeric fibers. 18 mRNA expression of collagen IV a4 remained relatively stable through all the observed time points in both B/W and BALB/c kidneys (Figure 2g ). Similar trends were seen for collagen IV a3 and a5 (data not shown). At the same time, expression of the remaining collagen IV chains, a1, a2, and a6, was significantly altered in the lupus prone mice. There was an age-related downregulation of collagen IV a1 and a2 mRNA levels in the BALB/c mice. In the B/W mice, collagen IV a1 and a2 mRNA levels followed the same pattern up to 20 weeks of age but then became significantly upregulated at the proteinuric stage compared with the 20 w.o. group (Figure 2h and i, Po0.05). Expression of collagen IV a6 was much higher in the B/W mice compared with their BALB/c counterparts at all time points studied (Figure 2j , Po0.01). mRNA expression of the collagen chains was also examined on microdissected glomeruli from prenephritic and nephritic mice, confirming that the alterations in collagen IV expression are of glomerular origin (Figure 2g-j, insets) . Next, we proceeded with analyses of gene expression of proteins involved in matrix degradation, focusing on MMP-2 and MMP-9, which are major contributors to collagen IV degradation. In contrast to stable, low-level expression of MMP-2 in BALB/c kidneys and young B/W, expression was increased more than 100-fold in three of five of the proteinuric B/W mice, whereas the remaining two showed doubling of expression levels compared with 20 w.o. B/W mice ( Figure 3a) . Whereas the expression of MMP-9 in normal mice decreased with age, a different trend was observed in the B/W, with a twofold upregulation in the proteinuric group compared with the age-matched BALB/c (Figure 3b , Po0.05). Recent studies have shown the 25 kDa protein lipocalin-2 (neutrophil gelatinase-associated lipocalin) to be a stabilizer of MMP-9 activity by preventing its degradation. 19 To evaluate possible contribution of lipocalin-2 to the renal damage in B/W mice, the expression level of lipocalin-2 was also determined. The proteinuric B/W showed a profound increase in lipocalin-2 expression, whereas stable, negligible mRNA levels were seen in BALB/c of all ages and younger B/W (Figure 3c , Po0.01).
Tissue inhibitors of metalloproteinases are the major negative modulators of MMP activity in vivo, and the Immunofluorescence analysis of MMPs and TIMPs localization revealed a significant increase in MMP-2 staining within the glomeruli of B/W mice between 20 weeks of age and the onset of proteinuria (Figure 4a and b) . The distribution of MMP-2 appeared relatively uniform throughout the mesangium in the 20 w.o. group, spreading into the capillary membranes upon development of proteinuria.
Matrix metalloproteinase-9 staining showed similar distribution, and was also significantly more intense in the proteinuric than in the younger mice (Figure 4c and d) . Antibodies against lipocalin-2 gave strong staining within the glomerular space of proteinuric B/W (Figure 4e ), whereas tubular staining was weaker and more scattered (data not shown). For TIMP-1, no staining could be detected in the younger B/W mice, whereas clearly positive fluorescent signal was detected predominately in the mesangium in the proteinuric animals ( Figure 4f ). TIMP-2 was distributed throughout the glomerular space, with scattered, weaker tubular signals, mainly in the periglomerular tubuli in the proteinuric mice (Figure 4g) . No staining could be detected when normal rabbit IgG substituted for primary antibody (Figure 4h ).
In situ zymography
Using a fluorescently labeled gelatin substrate, kidney sections were assayed for total gelatinolytic activity. BALB/c kidneys showed low level of gelatinolysis irrespective of age (Figure 5d ) B/W mice. Compared with both younger B/W and age-matched BALB/c, there was a dramatic increase in gelatinolytic activity in the glomeruli of proteinuric mice (Figure 5e ). No such changes were apparent within the peritubular space. Addition of the broadspectrum MMP inhibitor ethylenediaminetetraacetic acid (EDTA) (10 mM) to the reaction mixture was used to verify the contribution of MMPs to gelatinolysis in the nephritic B/W kidneys (Figure 5f ).
Gel zymography, immunoprecipitation and western blot analysis
To further characterize the observed gelatinolytic activity, cortical tissue homogenates were analyzed by gelatin zymography (Figure 5g ). There was evidence of increased enzymatic activity of pro-MMP-2 (72 kDa) in homogenates 
DISCUSSION
Glomerular basement membrane thickening and mesangial matrix expansion are significant morphological changes in lupus nephritis. Our data show that gene expression for the collagen IV isoform most abundant in the GBM (a3/a4/a5) remains relatively stable during the development of nephritis. At the same time, collagen IV a1 and a2 were increased at the onset of proteinuria. Also, the collagen IV a6 chain, normally found only in the parietal layer of Bowman's capsule, was upregulated in B/W at all time points, being particularly high at the proteinuric stage. Although we cannot at present exclude the possibility that changes in collagen IV a6 expression are unrelated to the development of nephritis, quantitative reverse transcription-PCR assays on kidneys from normal C57Bl/6 mice show an expression profile for collagen IV a6 similar to that of BALB/c (A. Tveita, unpublished data). Interestingly, there is a number of wellknown hereditary glomerulopathies associated with deposition of aberrant collagen IV networks, including Alport syndrome and thin basement membrane nephropathy, where switches in collagen IV isoforms expression toward a1/a2 are seen in the GBM. 20, 21 The presence of the a3/a4/a5 network has been shown to be important for the stability and proper functioning of the GBM, and its replacement by an a1/a2 network could lead to a nonfunctional glomerular filter. 22 Our data suggest that such a collagen IV isoform switch could occur around the time of onset of proteinuria. The relevance of these findings is a focus of ongoing investigations in our group.
Here, we present evidence for increased MMP-2 and MMP-9 expression and activity within the glomerular mesangial space coinciding with the appearance of morphological evidence of ECM expansion and the development of proteinuria in lupus-prone B/W mice. Data from gel zymography and immunofluorescence studies demonstrate MMP-9 as the main contributor to the increased gelatinolytic activity. This is in accordance with findings in several other models of glomerulonephritis. 10, 23 Interestingly, in our study, increase in MMP-9 gene expression at the onset of proteinuria is not as pronounced as for MMP-2. This suggests that some post-transcriptional mechanism is active in maintaining a high level of MMP-9 activity. Lipocalin-2 is a secreted protein that covalently binds to MMP-9 and protects it from autolysis. 19 In addition to its constitutive expression in neutrophils, lipocalin-2 is induced in a variety of epithelial cells in inflammatory conditions. 24 We find that lipocalin-2 gene expression is highly upregulated in the proteinuric B/W, and strong immunofluorescent staining for lipocalin-2 is present in glomeruli of proteinuric B/W. Also, zymography showed increased gelatinolytic activity corresponding to a neutrophil gelatinase-associated lipocalin/ MMP-9 complex. Stabilization by lipocalin-2 could thus explain the seemingly paradoxical findings of relatively stable MMP-9 gene expression and the increased contribution of MMP-9 to gelatinolytic activity in proteinuric B/W. Moreover, it was recently reported that urinary levels of lipocalin-2 correlated positively with renal disease activity in human systemic lupus erythematosus, and it has been proposed as a valuable early marker of the disease. 25 Accumulation of extracellular chromatin and the formation/deposition of immune complexes are observed by TEM as glomerular matrix-associated electron-dense structures in prenephritic stages of lupus nephritis development. 17, 26 By causing alterations in the composition or integrity of the membranes, increased MMP activity could potentially contribute to such a process, and this may be important in the initiation and/or maintenance of immune complex depositions. Additionally, immune complexes might be directly involved in the induction of increased MMP expression. 27, 28 In this manner, one could envision a synergic amplification of glomerular damage with increased proteolysis facilitating immune complex deposition. A recent study of the influence of anti-dsDNA autoantibodies on gene expression in isolated mesangial cells showed strong increase in lipocalin-2 production induced by several nephritogenic antibodies. 29 This could provide a direct link between autoantibody-induced signaling and the increase in gelatinolytic activity seen in our study.
Tissue inhibitors of metalloproteinase-1 expression level correlated strongly with the increase in MMP-2 expression at the proteinuric time point, which suggests a compensatory regulatory coupling between these antagonistic components. Interpreting MMP/TIMP balance in the context of ECM turnover alone is likely an oversimplification considering recent findings of the effects of both MMPs and TIMPs on a wide variety of cellular processes, including growth cycle progression, cellular proliferation, and apoptosis. [30] [31] [32] [33] More studies are needed to clarify the consequences of altered TIMP and MMP expression in lupus nephritis.
In summary, the net gelatinolytic activity within the glomeruli is significantly upregulated in murine lupus nephritis, and MMP-9 appears as the main contributor. Concomitantly, TIMP expression is increased, possibly through compensatory processes, but does not prevent the observed increase in gelatinolysis. Synthesis of normal GBM collagen IV isoform a3/a4/a5 appears relatively unchanged during the development of nephritis. The apparent expansion of glomerular membranes seen in the course of the disease could be due to qualitative alterations in the matrix structure, similarly to what has been proposed to occur in other types of nephropathies, 34, 35 with MMPs conceivably contributing by distorting matrix organization and causing changes that favor deposition of immune complexes within the membranes.
Understanding the pathophysiological consequences of altered MMP activity and alterations in membrane composition within the glomerulus might help to shed light on pathways involved in the development of lupus nephritis and could prove valuable in devising new therapeutic strategies.
MATERIALS AND METHODS Mice and tissue samples
Female BALB/c and B/W mice were purchased from Harlan (Blackthorn, UK). All experiments were approved by Norwegian Ethical and Welfare Board for Research Animals. Proteinuria in B/W mice was monitored weekly with sticks (Bayer Diagnostics, Bridgend, UK). Animals were euthanized by CO 2 suffocation at the age of 4, 8, and 20 weeks (Groups 1, 2, and 3, respectively) or upon development of proteinuria (43 g/l) (Group 4: X26 w.o. mice). Terminal blood samples collected from heart were used to prepare serum and stored at À20 1C. Kidneys were extirpated, cut, and preserved in RNAlater (Ambion Inc., TX, USA), fixed in 4% paraformaldehyde or McDowell's fixative for morphological studies by electron microscopy, 17 snap-frozen in liquid N 2 for protein extraction, or embedded in optimal cutting temperature compound and frozen in liquid N 2 for immunofluorescent microscopy. The same samples were obtained from gender-and age-matched BALB/c control mice.
Anti-dsDNA ELISA Serum antibodies against calf thymus dsDNA were detected and titrated by standard indirect ELISA, as described previously. 36 The murine monoclonal antibody 163p77, reactive with dsDNA and nucleosomes, and anti-DNA antibody-negative BALB/c serum was included as an intra-assay control. 37 Transmission electron microscopy For morphological studies by TEM, kidney tissue was treated according to standard procedures. 38 Micrographs were taken using a Jeol Transmission Electron Microscope (Tokyo, Japan).
Laser capture microdissection Ten-micrometer cryosections were prepared and immediately fixed in zinc buffer (40 mM ZnCl 2 , 30 mM ZnAc 2 Â 2H 2 O and 600 mM CaAc 2 in 0.1 M Tris, pH 7.4) for 5 min, stained with hematoxylin, dehydrated, air-dried, and overlaid with liquid coverglass (PALMZeiss, Bernreid, Germany). Glomeruli and tubuli were collected by laser capture microdissection on a PALM Laser-MicroBeam System. For each sample, 120 glomeruli and a corresponding surface-area of tubular tissue was collected, lyzed in Trizol (Invitrogen, Carlsbad, CA, USA), and stored at À70 1C.
cDNA synthesis Total RNA was isolated from RNAlater-preserved kidneys using EZ-1 RNA tissue mini kit (Qiagen, Nordic, Norway). The concentration of extracted RNA was determined spectrophotometrically with NanoDrop (NanoDrop technologies, Wilmington, DE, USA) and quality was assessed using Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Samples were reverse-transcribed with random primers using High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster City, CA, USA). For microdissected tissue, RNA was isolated by Trizol extraction on Phase Lock Heavy gel (Eppendorf Nordic, Horsholm, Denmark).
Real-time PCR analysis
Quantitative PCR was performed on ABI Prism 7900HT Sequence Detection System (Applied Biosystems) using predesigned TaqMan Gene Expression Assays (Applied Biosystems; accession numbers in the supplement). TATA box binding protein was used as an endogenous control. Relative expression levels were calculated using DDCt method.
Immunofluorescent microscopy
Four-micrometer-thick sections of optimal cutting temperature compound-embedded kidneys were blocked for 1 h with 10% calf serum and 1%BSA in phosphate-buffered saline (PBS) followed by washing and 30 min incubation with primary antibody (details in the supplement). Slides were washed and incubated for 30 min with Alexa-546-conjugated anti-rabbit F(ab) 2 secondary antibody (Invitrogen). Normal rabbit IgG was used as negative control.
In situ zymography
To detect the loci of ECM proteolytic activity within normal and nephritic kidney sections, an in situ zymography approach was employed. 28 Briefly, 8-mm-thick optimal cutting temperature compound-mounted kidney sections were washed in PBS and incubated for 2 h in DQ-labeled gelatin (Invitrogen) substrate solution (20 mg/ml DQ-gelatin, 50 mM Tris pH 6.8, 50 mM NaCl, 20 mM CaCl 2 ) at 37 1C in the dark. To verify the contribution of MMPs, control slides were pre-incubated for 1 h with 10 mM EDTA, a known inhibitor of gelatinase activity, and incubated in labeled DQ-substrate solution containing 10 mM EDTA. Substrate solution was washed off, slides were incubated in 4% formaldehyde for 10 min, washed with PBS, mounted with Glycergel mounting medium (Dako, Glostrup, Denmark), and photographed with identical exposure settings using a fluorescence microscope.
Gel zymography
Protein isolation was done as described previously. 39 Briefly, snapfrozen cortical tissue was homogenized in Tris buffer (0.5 mol/l TrisHCl, pH 7.5, 150 mmol/l NaCl) and centrifuged and the supernatant was collected. Pellet was resuspended in heat extraction buffer (50 mM Tris pH 7.5, 0.1 M CaCl 2 , 0.15 M NaCl), incubated for 4 min at 60 1C, and centrifuged, and the supernatant was collected. The supernatants were combined, and protein content was determined using BCA assay kit (Pierce Biochemicals, IL, USA). The samples were run on 7.5% SDS-PAGE containing gelatin (1.0 mg/ml) without previous heating or reduction. Following electrophoresis, gels were washed for 1 h in 2% Triton X-100 in 50 mM Tris-HCl, pH 7.4, followed by incubation at 37 1C for 20 h in activation buffer (50 mM Tris-HCl, pH 7.4, 5 mM CaCl 2 ). Gels were stained with Coomassie Blue. Clear zones in the background demonstrate the presence of protease activity. Control experiments were performed in the presence of 15 mM MMP inhibitor EDTA and 2 mM serine protease inhibitor Pefabloc SC (Fluka, Switzerland). The inhibitors were added for all incubation steps after electrophoresis. Pro-MMP-2 (MW 72 kDa), proMMP-9 (MW 92 kDa), and homodimeric MMP-9 form (MW 225 kDa) from human fibroblast cell lines were used as standards.
Immunoprecipitation
A total of 100 ml aliquots of aqueous suspension of protein ASepharose 4B (Sigma-Aldrich, Basel, Switzerland) were washed in cold PBS, mixed with 5 mg of polyclonal rabbit anti-mouse MMP-9 or anti-lipocalin-2 antibody, shaken for 35 min, and centrifuged. The pellet was incubated with 200 ml aliquots of kidney homogenate from nephritic B/W and incubated overnight at 4 1C. After centrifugation, pellets were washed extensively with ice-cold PBS, centrifuged, and resuspended in 50 ml of elution buffer (0.1 M glycine-HCl, pH 2.5); pH was subsequently adjusted by the addition of 5 ml of 1 M Tris pH 7.5. Aliquots of the immunoprecipitated proteins were heated to 95 1C for 3 min resolved by nonreducing SDS-PAGE and evaluated by Coomassie staining and western blot.
Western blot analysis SDS-polyacrylamide gel electrophoresis and western blotting were performed according to standard procedures. Membranes were blocked with 5% (w/v) skimmed milk for 1 h before application of primary antibody overnight at 4 1C. Binding was revealed by chemiluminescence detection. Determination of molecular weight was done by comparison with MagicMark XP molecular weight markers (Invitrogen).
Statistics
The results are presented as mean ± s.e.m. Comparison between groups was performed by two-way analysis of variance. Po0.05 was considered statistically significant.
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